跳至主要内容
临床试验/CTRI/2023/11/059761
CTRI/2023/11/059761尚未招募2 期

Efficacy of Homoeopathic Potentized Medicine Carcinosinum in Reduction of Serum Antibody levels of Hashimotos Thyroiditis; A Double Blind Randomized Placebo Controlled Trial - NI

Dr Rahitha K0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients from 18-60 years of age, All Genders.
  • 2.Patients with Anti TPO above 34 IU/mL and/or Anti Thyroglobulin above 64 IU/mL.
  • 3.Patients under Conventional Oral Hormone Replacement Therapy.

排除标准

  • 1.Cases with Malignant thyroid tumors.
  • 2.Patients with other severe systemic illness like uncontrolled diabetes, Malignant Hypertension, Severe cardiac diseases, Malignancies.
  • 3.Immuno-compromised patients- HIV/AIDS, TB.
  • 4.Pregnant women and Lactating mothers.

研究者

发起方
Dr Rahitha K

相似试验